glutathione mat2a

glutathione mat2a enhances PARN transcription via SRF to accelerate glycolysis and drive malignant progression in osteosarcoma Translocation of Methionine Adenosyl Transferase

Name: glutathione mat2a enhances PARN transcription via SRF to accelerate glycolysis and drive malignant progression in osteosarcoma Translocation of Methionine Adenosyl Transferase
Brand: uqtrucking.com
SKU: 15400697091
Price: 27.43 USD
Availability: InStock
Rating: 4.819000000000001 (20 reviews)

Translocation of Methionine Adenosyl Transferase MAT2A and Its Prognostic Relevance for Liver Hepatocellular Carcinoma Cardiac Energy Dependence on Glucose Increases Metabolites Related to Glutathione and Activates Metabolic Genes Controlled by Mechanistic Target of Rapamycin Journal of the American Heart Association Design and Structural Optimization of Methionine Adenosyltransferase 2A ( MAT2A) Inhibitors with High In Vivo Potency and Oral Bioavailability Journal of Medicinal Chemistry Overview of Methionine Adenosyltransferase 2A (MAT2A) as an Anticancer Target: Structure, Function, and Inhibitors Journal of Medicinal Chemistry MAT2A IN 11 MAT2A Inhibitor MedChemExpress

SKU: 15400697091 · From uqtrucking.com

4.8

USD27.43 USD76.43

Pay in 4 interest-free payments of $6.86 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

3729-C EMPOWERING THE FRONTLINE: ENHANCING HEPATITIS C TREATMENT ACCESSIBILITY IN PRIMARY CARE THROUGH PROCESS DESIGN AND RESIDENT EDUCATION Rita Auro, Michael Schwartz and Alexandra Lane, Cooper University Health Care Background: In 2022, the World Health Organization (WHO) recommended simplifying the hepatitis C virus (HCV) care pathway to improve treatment access, advocating for diagnosis and management in primary care (PC) settings